Terephthalic Acid

Terephthalic Acid

SCHEMBL5406537

NC(=O)N1CCCC1.O=C(O)c1ccc(C(=O)O)cc1

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1

The experimentally established mechanism targets of Terephthalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.52
ALDH1A1 P00352 3/20 0.52
TP53 P04637 1/20 0.50
TSHR P16473 1/20 0.50
GAA P10253 4/20 0.49
MAPT P10636 1/20 0.49
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
HTT P42858 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
MAPK1 P28482 1/20 0.47
KDM4E B2RXH2 2/20 0.46
HSD17B10 Q99714 1/20 0.46
POLB P06746 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
SRD5A2 P31213 1/20 0.44
CA12 O43570 3/20 0.44
CA1 P00915 3/20 0.44
CA2 P00918 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Aminobenzoic Acid SCHEMBL11794994 0.91 ALDH1A1 (0.48) HPGDALDH1A1TP53TSHRGAA
Isophthalic Acid SCHEMBL5406230 0.85 HPGD (0.57) HPGDALDH1A1GAAMAPTNPC1
Isophthalic Acid SCHEMBL5411490 0.83 HPGD (0.56) HPGDALDH1A1GAAMAPTNPC1
SCHEMBL70806 0.81 HPGD (0.79) HPGDALDH1A1TSHRMAPTMAPK1
SCHEMBL383556 0.79 LMNA (0.49) HPGDALDH1A1GAAMAPTRAB9A
SCHEMBL3905925 0.79 HPGD (0.83) HPGDALDH1A1TSHRMAPTMAPK1
SCHEMBL302276 0.79
SCHEMBL1363715 0.79
SCHEMBL7222401 0.78 CA12 (0.49) NPC1RAB9ACA12CA1CA2
SCHEMBL13126995 0.78 LMNA (0.56) HPGDALDH1A1TP53TSHRGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7173024-B2 Compounds having prolyl oligopeptidase inhibitory activity, methods for their preparation and their use ORION CORPORATION (FI) 2007-02-06 US disclosed
US-20050020677-A1 Compounds having prolyl oligopeptidase inhibitory activity, methods for their preparation and their use ORION CORPORATION (FI) 2005-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050020677-A1 Compounds having prolyl oligopeptidase inhibitory activity, methods for their preparation and their use DNPEP, PREP, ANPEP HPGD 713/4885ALDH1A1 827/4885TP53 1510/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.